liraglutide glp 1 analogue is a GLP-1 analog used primarily in the treatment of diabetes 2 and obesity. The global sales of it in 2022 was USD 1.7 billion. Now we have launched this product The GLP-1 Analogs Liraglutide and

the randomized trial investigated exenatide against a placebo control, 810 while the cohort and casecontrol studies compared either semaglutide, liraglutide, or tirzepatide against usual care management

doi: 10.1111/j.1464-5491.2005.01450.x

In animal studies, Janus kinase 1/2 inhibitors and Brutons tyrosine kinase inhibitors, other investigational agents for COVID-19 treatment 199 , improved glycaemia 200,201 and insulitis 200 and impaired the levels of anti-insulin B lymphocytes 202 and insulin antibodies 203 , which might have protective roles in T1DM

Less Common But Serious Side Effects Some rare but serious side effects need medical attention right away: Severe stomach pain that doesnt go away (could be pancreatitis) Allergic reactions Gallbladder problems Kidney issues Low blood sugar (if you also take diabetes medications) If you have any severe side effects, call your doctor right away

Red flags to revisit: Persistent fatigue, frequent illness, changes in hair or skin, dizziness, or ongoing digestive issues may signal a mismatch between your intake and your needs

We acknowledge that classification of gastrointestinal AEs, such as nausea, vomiting, diarrhea, constipation, dyspepsia, and reduced appetite, may vary across studies, which could introduce some heterogeneity in the reported incidences